Registration Strip Icon for default Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.

AVTR

Avantor (AVTR)

Avantor Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NYSE:AVTR
DataHoraFonteTítuloCódigoCompanhia
27/09/202409:05PR Newswire (US)Avantor® to Host Third Quarter 2024 Earnings Call on Friday, October 25, 2024NYSE:AVTRAvantor Inc
25/09/202410:05PR Newswire (US)Avantor® Joins Pharmaceutical Industry-Sponsored Energize Virtual Power Purchase AgreementNYSE:AVTRAvantor Inc
23/09/202409:05PR Newswire (US)Avantor® Participates in BioProcess International 2024 Conference Scientific Program and ExhibitionNYSE:AVTRAvantor Inc
12/09/202409:05PR Newswire (US)Avantor® Achieves Bronze Medal from EcoVadis for Sustainability PerformanceNYSE:AVTRAvantor Inc
06/09/202417:54Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:AVTRAvantor Inc
05/09/202415:59Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:AVTRAvantor Inc
22/08/202409:05PR Newswire (US)Avantor® to Participate in the Morgan Stanley 22nd Annual Global Healthcare ConferenceNYSE:AVTRAvantor Inc
16/08/202408:35PR Newswire (US)Avantor® Enters into Definitive Agreement to Divest Clinical Services Business to Audax Private EquityNYSE:AVTRAvantor Inc
08/08/202409:05PR Newswire (US)Wheels Up Announces Gregory Summe to Join Board of DirectorsNYSE:AVTRAvantor Inc
26/07/202410:02Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NYSE:AVTRAvantor Inc
26/07/202407:21Edgar (US Regulatory)Form 8-K - Current reportNYSE:AVTRAvantor Inc
26/07/202407:05PR Newswire (US)Avantor® Reports Second Quarter 2024 ResultsNYSE:AVTRAvantor Inc
23/07/202420:17PR Newswire (US)Avantor Set to Join S&P MidCap 400; QuidelOrtho & Schneider National to Join S&P SmallCap 600NYSE:AVTRAvantor Inc
10/07/202415:17Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NYSE:AVTRAvantor Inc
01/07/202409:05PR Newswire (US)Avantor® Announces New J.T.Baker® Cell Lysis Solution and J.T.Baker® EndonucleaseNYSE:AVTRAvantor Inc
28/06/202409:05PR Newswire (US)Avantor® to Host Second Quarter 2024 Earnings Call on Friday, July 26, 2024NYSE:AVTRAvantor Inc
21/06/202408:47PR Newswire (US)Avantor® Appoints Corey Walker as President of Laboratory SolutionsNYSE:AVTRAvantor Inc
18/06/202409:05PR Newswire (US)Avantor® Releases 2024 Science for Goodness Sustainability ReportNYSE:AVTRAvantor Inc
31/05/202417:29Edgar (US Regulatory)Form SD - Specialized disclosure reportNYSE:AVTRAvantor Inc
29/05/202409:05PR Newswire (US)Avantor® to Participate in Goldman Sachs Global Healthcare ConferenceNYSE:AVTRAvantor Inc
21/05/202409:05PR Newswire (US)Avantor® to Participate in Bernstein's 40th Annual Strategic Decisions ConferenceNYSE:AVTRAvantor Inc
03/05/202409:05PR Newswire (US)Avantor® to Participate in BofA Securities 2024 Health Care ConferenceNYSE:AVTRAvantor Inc
26/04/202407:00PR Newswire (US)Avantor® Reports First Quarter 2024 ResultsNYSE:AVTRAvantor Inc
01/04/202409:00PR Newswire (US)Avantor® to Host First Quarter 2024 Earnings Call on Friday, April 26, 2024NYSE:AVTRAvantor Inc
26/02/202410:05PR Newswire (US)Avantor® Celebrates Supplier Award Honorees at 2024 European Sales ConferenceNYSE:AVTRAvantor Inc
20/02/202410:05PR Newswire (US)Avantor® to Participate in the 44th Annual TD Cowen Health Care ConferenceNYSE:AVTRAvantor Inc
14/02/202412:04Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NYSE:AVTRAvantor Inc
14/02/202409:09Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NYSE:AVTRAvantor Inc
14/02/202408:00PR Newswire (US)Avantor® Reports Fourth Quarter and Full Year 2023 ResultsNYSE:AVTRAvantor Inc
24/01/202410:05PR Newswire (US)Avantor® to Report Fourth Quarter and Full Year 2023 Earnings on Wednesday, February 14, 2024NYSE:AVTRAvantor Inc
 Apresentando as notícias mais relevantes sobre:NYSE:AVTR

Seu Histórico Recente